Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells
- PMID: 28994018
- DOI: 10.1007/s13402-017-0352-6
Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells
Abstract
Background: The compartments of memory T cells play a fundamental role in the immune system by substantiating specific and acquired immunity. A new subset of memory cells, T stem cell memory (TSCM) cells, with stem cell-like properties, a high capacity to proliferate, a long survival, and an ability to differentiate into all effector and memory cells has recently been introduced. In the present study, we aimed to determine the frequency of CD4+ TSCM and other T memory cell subsets in tumor draining lymph nodes of breast cancer patients.
Materials and methods: Mononuclear cells were obtained from axillary lymph nodes of 52 untreated patients with breast cancer (BC) and stained with fluorochrome conjugated anti-CD4, -CCR7, -CD45RO and -CD95 antibodies to detect different subtypes of memory cells in CD4+ lymphocyte populations. Data were acquired using a four-color FACSCalibur flow cytometer and analyzed using CellQuest Pro software.
Results: We found that >70% of CD4+ lymphocytes in draining lymph nodes of BC patients exhibited a memory phenotype of which 7.04 ± 1.04% had a TSCM phenotype (CD4+CCR7+CD45RO-CD95+). The frequency of TSCM cells was significantly higher in tumor positive lymph nodes compared to tumor negative lymph nodes (p = 0.026) as well as among those patients who had at least one affected lymph node (p = 0.012). Moreover, we found that the total frequency of central memory T cells (TCM) with a low expression of CD45RO was significantly higher among these patients. The percentage of CD45ROLow TCM cells was also found to increase with tumor progression from stage I to stage III (p = 0.020). On the other hand, we found that the percentage of CD95Hi effector memory T cells (TEM) was significantly decreased in involved lymph nodes (p = 0.009).
Conclusion: Our data suggest that following long-term exposure to putative tumor antigens, TSCM cells proliferate to generate a pool of committed memory and effector T cells. As the tumor progresses, the immunosuppressive milieu induced by tumor cells may slow down the differentiation of CD45ROLow TCM cells to more functional sub-populations.
Keywords: Breast cancer; CD4+ T stem cell memory cells; Lymph node.
Similar articles
-
CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer.BMC Cancer. 2020 Mar 30;20(1):257. doi: 10.1186/s12885-020-6714-x. BMC Cancer. 2020. PMID: 32228503 Free PMC article.
-
Diversity of Memory CD8+ T Cells in Tumor-Draining Lymph Nodes from Patients with Bladder Cancer.Int J Mol Cell Med. 2024;13(2):147-159. doi: 10.22088/IJMCM.BUMS.13.2.147. Int J Mol Cell Med. 2024. PMID: 39184818 Free PMC article.
-
Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.Immunol Lett. 2014 Mar-Apr;158(1-2):57-65. doi: 10.1016/j.imlet.2013.11.021. Epub 2013 Dec 8. Immunol Lett. 2014. PMID: 24326038
-
T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values.Front Immunol. 2023 Jul 11;14:1204231. doi: 10.3389/fimmu.2023.1204231. eCollection 2023. Front Immunol. 2023. PMID: 37497231 Free PMC article. Review.
-
Lymph nodes and human tumors (review).Int J Mol Med. 1998 Apr;1(4):729-33. doi: 10.3892/ijmm.1.4.729. Int J Mol Med. 1998. PMID: 9852289 Review.
Cited by
-
Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer.J Immunother Cancer. 2021 Apr;9(4):e002343. doi: 10.1136/jitc-2021-002343. J Immunother Cancer. 2021. PMID: 33795388 Free PMC article.
-
The oncogenic role of tubulin alpha-1c chain in human tumours.BMC Cancer. 2022 May 6;22(1):498. doi: 10.1186/s12885-022-09595-0. BMC Cancer. 2022. PMID: 35513790 Free PMC article.
-
Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.Cell Oncol (Dordr). 2019 Jun;42(3):343-356. doi: 10.1007/s13402-019-00430-6. Epub 2019 Mar 1. Cell Oncol (Dordr). 2019. PMID: 30825183
-
Immune infiltration in nasopharyngeal carcinoma based on gene expression.Medicine (Baltimore). 2019 Sep;98(39):e17311. doi: 10.1097/MD.0000000000017311. Medicine (Baltimore). 2019. PMID: 31574860 Free PMC article.
-
Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach.J Extracell Biol. 2024 Sep 26;3(9):e70011. doi: 10.1002/jex2.70011. eCollection 2024 Sep. J Extracell Biol. 2024. PMID: 39328262 Free PMC article. Review.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials